📣 VC round data is live. Check it out!

Concord Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Concord Medical and similar public comparables like Hyperfine, Fonar, EuroEyes Eye Clinic, Centrum Medyczne ENEL-MED and more.

Concord Medical Overview

About Concord Medical

Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The company caters to both cancer patients and third-party medical institutions. It operates its own medical institutions to provide comprehensive oncology healthcare services to cancer patients using its medical professionals and precision radiation therapy. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is generated from its hospital business and its medical equipment, software, and related services segment. Substantially all of the company's revenue is generated from the PRC.


Founded

2008

HQ

China

Employees

567

Financials (FY)

Revenue: $68M
EBITDA: ($5M)

EV

$541M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Concord Medical Financials

Concord Medical reported last fiscal year revenue of $68M and negative EBITDA of ($5M).

In the same fiscal year, Concord Medical generated $5M in gross profit, ($5M) in EBITDA losses, and had net loss of ($38M).


Concord Medical P&L

In the most recent fiscal year, Concord Medical reported revenue of $68M and EBITDA of ($5M).

Concord Medical is unprofitable as of last fiscal year, with gross margin of 7%, EBITDA margin of (7%), and net margin of (56%).

See analyst estimates for Concord Medical
Last FY202320242025202620272028
Revenue$68M$79M$57M$68M
Gross Profit$5M($10M)($10M)$5M
Gross Margin7%(12%)(17%)7%
EBITDA($5M)($25M)($35M)($5M)
EBITDA Margin(7%)(32%)(61%)(7%)
EBIT Margin(48%)(66%)(102%)(48%)
Net Profit($38M)($55M)($65M)($38M)
Net Margin(56%)(69%)(114%)(56%)
Net Debt$396M

Financial data powered by Morningstar, Inc.

Concord Medical Stock Performance

Concord Medical has current market cap of $130M, and enterprise value of $541M.

Market Cap Evolution


Concord Medical's stock price is $0.17.

Concord Medical share price decreased by 18.7% in the last 30 days, and by 81.0% in the last year.

Concord Medical has an EPS (earnings per share) of $-0.05.

See more trading valuation data for Concord Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$541M$130M-2.3%-18.7%-10.9%-81.0%$-0.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Concord Medical Valuation Multiples

Concord Medical trades at 8.0x EV/Revenue multiple, and (110.1x) EV/EBITDA.

See NTM and 2027E valuation multiples for Concord Medical

Concord Medical Financial Valuation Multiples

As of May 20, 2026, Concord Medical has market cap of $130M and EV of $541M.

Concord Medical has a P/E ratio of (3.4x).

Last FY202320242025202620272028
EV/Revenue8.0x6.8x9.5x8.0x
EV/EBITDA(110.1x)(21.3x)(15.5x)(110.1x)
EV/EBIT(16.8x)(10.4x)(9.2x)(16.8x)
EV/Gross Profit115.0x(56.5x)(54.7x)115.0x
P/E(3.4x)(2.4x)(2.0x)(3.4x)
EV/FCF(14.1x)203.0x(7.2x)(14.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Concord Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Concord Medical Margins & Growth Rates

In the most recent fiscal year, Concord Medical reported gross margin of 7%, EBITDA margin of (7%), and net margin of (56%).

See estimated margins and future growth rates for Concord Medical

Concord Medical Margins

Last FY20242025202720282029
Gross Margin7%(17%)7%
EBITDA Margin(7%)(61%)(7%)
EBIT Margin(48%)(102%)(48%)
Net Margin(56%)(114%)(56%)
FCF Margin(57%)(132%)(57%)

Concord Medical Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(28%)18%
Gross Profit Growth3%(148%)
EBITDA Growth37%(86%)
EBIT Growth12%(45%)
Net Profit Growth19%(42%)
FCF Growth(2925%)(49%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Concord Medical Operational KPIs

Concord Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Concord Medical
Last FY202320242025202620272028
Revenue per Employee$0.1M
Opex per Employee$0.1M
S&M Expenses to Revenue11%10%13%11%
G&A Expenses to Revenue29%37%54%29%
R&D Expenses to Revenue6%7%8%6%
Opex to Revenue54%54%85%54%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Concord Medical Competitors

Concord Medical competitors include Hyperfine, Fonar, EuroEyes Eye Clinic, Centrum Medyczne ENEL-MED, Suraksha Diagnostics, Limes Schlosskliniken, FamiCord, Athens Medical Centre, Clinica Las Condes and Goodwill Pharma.

Most Concord Medical public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Hyperfine8.3x7.0x(3.2x)(3.3x)
Fonar1.0x5.6x
EuroEyes Eye Clinic0.7x2.4x
Centrum Medyczne ENEL-MED1.0x7.9x
Suraksha Diagnostics5.7x5.4x17.9x17.3x
Limes Schlosskliniken2.7x2.5x10.8x9.7x
FamiCord0.9x0.9x(171.6x)7.5x
Athens Medical Centre1.1x11.0x

This data is available for Pro users. Sign up to see all Concord Medical competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Concord Medical

When was Concord Medical founded?Concord Medical was founded in 2008.
Where is Concord Medical headquartered?Concord Medical is headquartered in China.
How many employees does Concord Medical have?As of today, Concord Medical has over 567 employees.
Is Concord Medical publicly listed?Yes, Concord Medical is a public company listed on HKEX.
What is the stock symbol of Concord Medical?Concord Medical trades under 02453 ticker.
When did Concord Medical go public?Concord Medical went public in 2024.
Who are competitors of Concord Medical?Concord Medical main competitors include Hyperfine, Fonar, EuroEyes Eye Clinic, Centrum Medyczne ENEL-MED, Suraksha Diagnostics, Limes Schlosskliniken, FamiCord, Athens Medical Centre, Clinica Las Condes, Goodwill Pharma.
What is the current market cap of Concord Medical?Concord Medical's current market cap is $130M.
What is the current revenue of Concord Medical?Concord Medical's last fiscal year revenue is $68M.
What is the current EV/Revenue multiple of Concord Medical?Current revenue multiple of Concord Medical is 8.0x.
Is Concord Medical profitable?No, Concord Medical is not profitable.
How many companies Concord Medical has acquired to date?Concord Medical hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Concord Medical has invested to date?Concord Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Concord Medical

Lists including Concord Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial